I just got an e-mail from Jonathan where he tried to answer on my last few e-mails to him. Here is my last e-mail and his complete answer ( it would be nice if you would do the same).
ME: Hi Jonathan,
There is very strong concern among shareholders about the issuance by the management of 33 mil restricted shares for salary considering present situation with the company and 6 days right after knocking down our shares by 12 times.
We would appreciate your farther explanation specifically to your long term loyal shareholders.
Also there is an additional 1,709,647 shares were added prior to a total of 45,864,192 shares.
All the numbers are taken from your latest Quarterly Report.
Also I would like specific details about European "signed agreement" which "will generate significant revenue in 2006".
Regards,
-----------------------------------------------------------------
Jonathan:
33m shares is half of what I have personally pout into the company. They are restricted for the pre-requisite 2 years. They cannot be sold not utilised for two years. They were used to protect the company and to ensure that I continue to take the company forward. How many people would work under these circumstances for a net loss personally. Now the blogs are attacking me personally and publish private details which affect my family.
Below are some answers I have put to other investors.
To answer you specific question, the ultimate position of national launch to the NHS is upon us. The meeting as I have already said went far better than could be wished for and in fact the product is now to be available to Doctors and Nurses. This way brought forward by the NHS.
If I deliver the national product launch and revenue to justify $25 share price, then no-one would have any issues. So let me get on with my job because that is where we are at and the continual personal abuse I get is not helping.
Jonathan.
We want to maintain control of the company so that we are not victims of a a hostile bid. The German and Asian floats are not off they are just delayed. Imagine the result if we float on the back of the NHS national product launch? This news will also take the pps north.
The view of management is to grow on the back of the NHS news into a global concern. The NHS market alone is worth $1.3bn dollars per annum - that is the budget available to pay for MedifyRemote. Our contracts with the PCTs are for a minimum of 18 months. Thus we would be stupid to sell out now.
On the back of the EMIS news we are already in negotiation with 6 PCTS in addition to Doncaster. Using basic and simple numbers. There are approximately 350 PCTs in the UK. !92 of these (55%) are EMIS customers.
We are currently in negotiation with 7 (6 new plus Doncaster) which is 4%.
So in the fist week we are at 4% in terms of providing the product to EMIS users. Remember 10% = $7.4m revenue and $5.8m profit.
To be here at week one is phenomenal and to be in a position whereby the NHS is about to launch the product nationally is unbelievable and thus a sell out at the moment should not be considered.
